- Home
- IMMP vs LEGT Comparison
IMMP vs LEGT Comparison
Compare IMMP & LEGT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMMP
- LEGT
- Stock Information
- Founded
- IMMP 1987
- LEGT 2023
- Country
- IMMP Australia
- LEGT United States
- Employees
- IMMP N/A
- LEGT N/A
- Industry
- IMMP Biotechnology: Pharmaceutical Preparations
- LEGT
- Sector
- IMMP Health Care
- LEGT
- Exchange
- IMMP Nasdaq
- LEGT Nasdaq
- Market Cap
- IMMP 251.8M
- LEGT 276.8M
- IPO Year
- IMMP N/A
- LEGT 2024
- Fundamental
- Price
- IMMP $1.64
- LEGT $10.77
- Analyst Decision
- IMMP Buy
- LEGT
- Analyst Count
- IMMP 1
- LEGT 0
- Target Price
- IMMP $7.00
- LEGT N/A
- AVG Volume (30 Days)
- IMMP 87.8K
- LEGT 21.9K
- Earning Date
- IMMP 10-21-2025
- LEGT 01-01-0001
- Dividend Yield
- IMMP N/A
- LEGT N/A
- EPS Growth
- IMMP N/A
- LEGT N/A
- EPS
- IMMP N/A
- LEGT 0.35
- Revenue
- IMMP $3,306,742.00
- LEGT N/A
- Revenue This Year
- IMMP N/A
- LEGT N/A
- Revenue Next Year
- IMMP $725.37
- LEGT N/A
- P/E Ratio
- IMMP N/A
- LEGT $30.68
- Revenue Growth
- IMMP 31.28
- LEGT N/A
- 52 Week Low
- IMMP $1.32
- LEGT $10.18
- 52 Week High
- IMMP $2.71
- LEGT $10.86
- Technical
- Relative Strength Index (RSI)
- IMMP 46.06
- LEGT 61.22
- Support Level
- IMMP $1.60
- LEGT $10.72
- Resistance Level
- IMMP $1.68
- LEGT $10.78
- Average True Range (ATR)
- IMMP 0.07
- LEGT 0.01
- MACD
- IMMP -0.00
- LEGT 0.00
- Stochastic Oscillator
- IMMP 28.12
- LEGT 83.33
About IMMP Immutep Limited
Immutep Ltd is a globally active biotechnology company developing immunotherapy products for cancer and autoimmune diseases. Its main product is IMP321, which involves clinical development for the treatment of cancer indications. The company is also focused on the development of other products, which include IMP701, which is a blocking anti-LAG-3 antibody for cancer and is in Phase I of its clinical trials, and CVac, which is a personalized immunocellular therapeutic investigated for the treatment of epithelial cancer. Geographically all the business activity of the firm is functioned through the region of Australia.
About LEGT Legato Merger Corp. III
Legato Merger Corp III is a blank check company.